{"References": [{"title": "The endocannabinoid system: an overview", "authors": "Vincenzo Di Marzo, Luciano De Petrocellis", "journal": "Frontiers in Behavioral Neuroscience", "year": "2012", "volumes": "6", "first page": "9", "last page": "9", "DOI": "10.3389/fnbeh.2012.00009"}, {"title": "Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system", "authors": "Nephi Stella, Andrea A. Schweitzer, Ken Mackie", "journal": "International Review of Neurobiology", "year": "2002", "volumes": "63", "first page": "187", "last page": "261", "DOI": "10.1016/S0074-7742(02)63005-2"}, {"title": "Endocannabinoid signaling in the brain", "authors": "Daniele Piomelli", "journal": "Nature Reviews Neuroscience", "year": "2003", "volumes": "4", "first page": "873", "last page": "884", "DOI": "10.1038/nrn1247"}, {"title": "The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction", "authors": "Francisco Navarrete, José Antonio García-Gutiérrez, Jorge Manzanares", "journal": "Addiction Biology", "year": "2021", "volumes": "26", "first page": "e12848", "last page": "e12848", "DOI": "10.1111/adb.12848"}, {"title": "Cannabidiol as a potential treatment for anxiety disorders", "authors": "Carl L. Hart, Yasmin L. Hurd", "journal": "Neurotherapeutics", "year": "2020", "volumes": "17", "first page": "968", "last page": "980", "DOI": "10.1007/s13311-020-00810-1"}, {"title": "Endocannabinoid-like N-acylethanolamines and their structural analogs", "authors": "Vincenzo Di Marzo, Luciano De Petrocellis", "journal": "Cellular and Molecular Life Sciences", "year": "2006", "volumes": "63", "first page": "1597", "last page": "1615", "DOI": "10.1007/s00018-006-6093-8"}, {"title": "The endocannabinoid system and its modulation by phytocannabinoids", "authors": "Roger G. Pertwee", "journal": "Neuropharmacology", "year": "2010", "volumes": "58", "first page": "105", "last page": "115", "DOI": "10.1016/j.neuropharm.2009.07.028"}, {"title": "Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids", "authors": "Vincenzo Di Marzo, Luciano De Petrocellis", "journal": "Handbook of Experimental Pharmacology", "year": "2005", "volumes": "168", "first page": "147", "last page": "185", "DOI": "10.1007/3-540-26573-2_5"}, {"title": "Cannabinoid pharmacology: the first 66 years", "authors": "Raphael Mechoulam, Linda A. Parker", "journal": "British Journal of Pharmacology", "year": "2013", "volumes": "170", "first page": "147", "last page": "158", "DOI": "10.1111/bph.12144"}, {"title": "The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants", "authors": "José Antonio García-Gutiérrez, Francisco Navarrete, Jorge Manzanares", "journal": "Frontiers in Pharmacology", "year": "2020", "volumes": "11", "first page": "587", "last page": "587", "DOI": "10.3389/fphar.2020.00587"}]}